Call Us Sign-Up/Sign-In
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

ACE Inhibitors Market Latest Amendments 2019-2025 By: Par Pharmaceutical Companies, Inc, UCB, Inc, Pfizer, Inc, AbbVie, AstraZeneca

iCrowdNewswire   Jan 27, 2021  11:48 AM ET

The growth of the global ACE inhibitors market is determined by numerous factors such as rising adoption of ACE inhibitors for the treatment of cardiovascular complications and diabetic neuropathy, rising cases of cardiovascular disorders such as hypertension, and surge in demand for less expensive drugs.

For instance, according to the data published by the World Health Organization (WHO) in 2017, the global prevalence rate of raised blood pressure in adults aged more than 18 was estimated to be 22.1% in 2017. However, side effects associated with the treatment and high costs of treatment are likely to hamper the growth of the global ACE inhibitors market during the forecast period.

According to MRFR analysis, ACE Inhibitors Market is expected to register a CAGR of 3.10% during the forecast period of 2019 to 2025 and is likely to be valued at USD 7682.8 Million in 2025.  

Market Segmentation

The Global ACE Inhibitors Market has been segmented based on Product, Application, Dosage Form, and Distribution Channel.

The market, based on product, has been divided into lisinopril, ramipril, enalapril, benazepril, fosinopril, captopril, moexipril, and others. The lisinopril is likely to hold the maximum market share in the global ACE inhibitors market owing to the growing adoption of lisinopril in the management of cardiovascular complications and diabetic neuropathy.

Request Free Sample Copy of Report with Detailed Impact Analysis of Covid-19:

The global ACE inhibitors market based on the application has been segregated into heart failure, hypertension, diabetes, heart attack, chronic kidney disease, and others. The hypertension segment is expected to hold a larger share of the market share owing to the rising cases of hypertension and the adoption of ACE inhibitors.

The dosage form segment of the market is divided into oral tablets and oral solution. Capoten, Vasotec, Prinivil, Zestril, Lotensin, Monopril, and Altace are some well-known and widely used oral tablets.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the growing prevalence of hypertension and cardiovascular disorders.      

Have Any Query? Connect with Our Research Expert 24*7: 

The European ACE inhibitors market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The ACE inhibitors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. 

Key Players

Some of the Key Players in the Global ACE Inhibitors Market are Bristol-Myers Squibb Company (US), Par Pharmaceutical Companies, Inc. (US), UCB, Inc. (Belgium), Pfizer, Inc.(US), AbbVie Inc.(US), AstraZeneca (UK), Bausch Health Companies Inc.(Canada), Novartis AG (Switzerland), Merck & Co., Inc.(US), Teva Pharmaceutical Industries Ltd.(Israel), Silvergate Pharmaceuticals, Inc. (US), and others.

Access Full Summary of Report:

About Market Research Future:

Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.

Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.

Contact Information:

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312

Keywords:    ACE Inhibitors Market, ACE Inhibitors, ACE Inhibitors Market Size, ACE Inhibitors Market Share, ACE Inhibitors Market Growth, ACE Inhibitors Market Trends, ACE Inhibitors Market Forecast, ACE Inhibitors Market Growth, ACE Inhibitors Market Analysis

Tags:    Reportedtimes, Research Newswire, English